Total Visits

Views
A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: A study of the EORTC early clinical studies group (ECSG)114

Total Visits Per Month

August 2023September 2023October 2023November 2023December 2023January 2024February 2024
A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: A study of the EORTC early clinical studies group (ECSG)20001721

Top country views

Views
Poland52
United States50
France3
Ireland2
Germany1
EU1
Greece1
Russia1
Sweden1
Togo1

Top cities views

Views
Warsaw52
Boardman10
Des Moines9
Louisville9
San Ramon8
Ann Arbor5
Dublin2
Fairfield2
Ashburn1
Athens1